Pr-liver, lesion(s) after Etodolac in dogs
55 reports to the FDA describe pr-liver, lesion(s) in dogs given Etodolac. That is 2.9% of all reports for this medicine, compared with 0.3% across reports for all dog medicines, so it is reported unusually often with this medicine.
55Reports
0.0%Marked serious
0.0%Recovered
58%Died or euthanised
–Typical onset
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Type: medicine.
Questions owners ask
- Can Etodolac cause pr-liver, lesion(s) in dogs?
- 55 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Pr-liver, lesion(s) with similar medicines
- Pr-liver, lesion(s) after Polysulfated Glycosaminoglycan 22 reports · 0.4% of its reports
- Pr-liver, lesion(s) after Cefpodoxime 28 reports · 0.7% of its reports
- Pr-liver, lesion(s) after Dirlotapide 21 reports · 0.7% of its reports
- Pr-liver, lesion(s) after Medetomidine 23 reports · 1.1% of its reports
All reported side effects of Etodolac in dogs · Medicines most reported with pr-liver, lesion(s)
